MedPath

REVEAL for Respiration Detection

Not Applicable
Conditions
Unexplained Syncope
Suspected Arrhythmia
Registration Number
NCT01956578
Lead Sponsor
Medtronic BRC
Brief Summary

This study will evaluate the correlation between the respiratory rate derived from the Reveal Insertable Cardiac Monitor (ICM) electrocardiogram (ECG) with the respiratory rate obtained from an external respiratory band in patients previously implanted with a Reveal for unexplained syncope or suspected arrhythmia.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Subject is implanted with a Reveal ICM or Reveal XT ICM for unexplained syncope or suspected arrhythmia
  • Subject (or the legal representative) is willing to sign informed consent form
  • Subject is 18 years or older or as specified minimal age per local law/regulation
Exclusion Criteria
  • Significant respiratory diseases such as COPD or pulmonary hypertension.
  • Patients with frequent arrhythmias, including PVC's.
  • Patients with known heart failure.
  • Body conditions that would complicate accurate measurement of respiratory rate with the respiration device.
  • Patients which are not able to take the postures as necessary for the study protocol and which cannot walk continuously for a period of 6 minutes.
  • Pregnant or breastfeeding women, or women of child bearing potential and who are not on a reliable form of birth control.
  • Subject is enrolled in one or more concurrent studies that would confound the results of this study

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Respiration rate derived from the Reveal ICM ECG correlated with the respiration rate from the external respiratory band during a three minute period of normal breathing.Up to 3 minutes
Secondary Outcome Measures
NameTimeMethod
Respiration rate obtained from the REVEAL ICM ECG with the respiratory rate obtained from external respiratory band during three minute periods of periodic, controlled breathing and elevated heart rate.Up to 3 minutes

Trial Locations

Locations (1)

Diakonessenhuis

🇳🇱

Utrecht, Netherlands

Diakonessenhuis
🇳🇱Utrecht, Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.